Breaking News Instant updates and real-time market news.

SBUX

Starbucks

$56.11 /

-1.89 (-3.26%)

13:22
03/23/20
03/23
13:22
03/23/20
13:22

Pershing Square's Bill Ackman says bought stock in Starbucks

Ackman is speaking on Bloomberg TV.

SBUX Starbucks
$56.11 /

-1.89 (-3.26%)

03/23/20
Fly Intel: Top five analyst downgrades
03/23/20 MKM Partners
Starbucks downgraded to Neutral from Buy at MKM Partners
03/23/20 MKM Partners
Starbucks downgraded to Neutral from Buy at MKM Partners
03/10/20 Jefferies
Starbucks price target lowered to $95 from $110 at Jefferies

TODAY'S FREE FLY STORIES

Hot Stocks
Oppenheimer & Co. to acquire Brandis Tallman, terms not disclosed » 08:02
06/01/20
06/01
08:02
06/01/20
08:02
OPY

Oppenheimer Holdings

$21.30 /

-0.01 (-0.05%)

Oppenheimer & Co., a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPY Oppenheimer Holdings
$21.30 /

-0.01 (-0.05%)

Conference/Events
Banc of California management to meet virtually with Piper Sandler » 08:01
06/01/20
06/01
08:01
06/01/20
08:01
BANC

Banc of California

$10.97 /

-0.43 (-3.77%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BANC Banc of California
$10.97 /

-0.43 (-3.77%)

BANC Banc of California
$10.97 /

-0.43 (-3.77%)

04/13/20 B. Riley FBR
Banc of California upgraded to Neutral from Sell at B. Riley FBR
02/11/20 B. Riley FBR
Banc of California buyback program a 'modest positive,' says B. Riley FBR
01/24/20 B. Riley FBR
B. Riley downgrades Banc of California to Sell, says strategic sale unlikely
01/24/20 B. Riley FBR
Banc of California downgraded to Sell from Neutral at B. Riley FBR
BANC Banc of California
$10.97 /

-0.43 (-3.77%)

Hot Stocks
Myovant Sciences submits NDA for relugolix combination tablet » 08:01
06/01/20
06/01
08:01
06/01/20
08:01
MYOV

Myovant Sciences

$12.24 /

+0.17 (+1.41%)

Myovant Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYOV Myovant Sciences
$12.24 /

+0.17 (+1.41%)

MYOV Myovant Sciences
$12.24 /

+0.17 (+1.41%)

02/03/20 Citi
Myovant Sciences resumed with a Neutral from Buy at Citi
11/19/19 Goldman Sachs
Myovant Sciences price target raised to $20 from $18 at Goldman Sachs
11/19/19 JMP Securities
JMP boosts Myovant price target to $34 after 'compelling' prostate cancer data
08/28/19
Fly Intel: Top five analyst initiations
MYOV Myovant Sciences
$12.24 /

+0.17 (+1.41%)

MYOV Myovant Sciences
$12.24 /

+0.17 (+1.41%)

MYOV Myovant Sciences
$12.24 /

+0.17 (+1.41%)

Options
Uber call buyer realizes 56% same-day gains » 08:00
06/01/20
06/01
08:00
06/01/20
08:00
UBER

Uber

$36.34 /

+2.175 (+6.37%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$36.34 /

+2.175 (+6.37%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/27/20 Northcoast
Ride hailing drivers believe April marked the bottom, says Northcoast
05/26/20 Wolfe Research
Uber upgraded to Outperform from Peer Perform at Wolfe Research
05/15/20 Wedbush
Uber's potential GrubHub deal an offensive and defensive move, says Wedbush
UBER Uber
$36.34 /

+2.175 (+6.37%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

UBER Uber
$36.34 /

+2.175 (+6.37%)

Hot Stocks
Schultze Special Purpose Acquisition Corporation trading resumes  08:00
06/01/20
06/01
08:00
06/01/20
08:00
SAMA

Schultz Special Purpose Acquisition

$10.19 /

+ (+0.00%)

 
ShowHide Related Items >><<
SAMA Schultz Special Purpose Acquisition
$10.19 /

+ (+0.00%)

Hot Stocks
Schultze Special Purpose Acquisition Corporation (Units) trading resumes  08:00
06/01/20
06/01
08:00
06/01/20
08:00
 
Upgrade
FormFactor upgraded to Buy from Neutral at DA Davidson » 07:59
06/01/20
06/01
07:59
06/01/20
07:59
FORM

FormFactor

$25.15 /

+0.44 (+1.78%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FORM FormFactor
$25.15 /

+0.44 (+1.78%)

FORM FormFactor
$25.15 /

+0.44 (+1.78%)

06:38 Today DA Davidson
FormFactor upgraded to Buy from Neutral at DA Davidson
04/17/20
Fly Intel: Top five analyst initiations
04/17/20 Cowen
FormFactor initiated with a Market Perform at Cowen
04/02/20 DA Davidson
FormFactor downgraded to Neutral from Buy at DA Davidson
FORM FormFactor
$25.15 /

+0.44 (+1.78%)

Earnings
Thermon Group reports Q4 adj. EPS 1c, consensus 17c » 07:58
06/01/20
06/01
07:58
06/01/20
07:58
THR

Thermon Group

$16.11 /

-0.28 (-1.71%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THR Thermon Group
$16.11 /

-0.28 (-1.71%)

03/16/20
Fly Intel: Top five analyst initiations
03/16/20 Rosenblatt
Thermon Group initiated with a Buy at Rosenblatt
Periodicals
Barclays to return about 700 staff to offices in July, Bloomberg reports » 07:58
06/01/20
06/01
07:58
06/01/20
07:58
BCS

Barclays

$5.66 /

-0.245 (-4.15%)

Barclays will begin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCS Barclays
$5.66 /

-0.245 (-4.15%)

BCS Barclays
$5.66 /

-0.245 (-4.15%)

05/29/20 Investec
Barclays downgraded to Hold from Buy at Investec
05/21/20 Exane BNP Paribas
Barclays downgraded to Neutral from Outperform at Exane BNP Paribas
05/04/20 UBS
Barclays price target lowered to 140 GBp from 150 GBp at UBS
05/04/20 JPMorgan
Barclays price target lowered to 160 GBp from 180 GBp at JPMorgan
BCS Barclays
$5.66 /

-0.245 (-4.15%)

BCS Barclays
$5.66 /

-0.245 (-4.15%)

BCS Barclays
$5.66 /

-0.245 (-4.15%)

BCS Barclays
$5.66 /

-0.245 (-4.15%)

Recommendations
Harpoon Therapeutics price target raised to $36 from $26 at Wedbush » 07:57
06/01/20
06/01
07:57
06/01/20
07:57
HARP

Harpoon Therapeutics

$21.40 /

+0.66 (+3.18%)

Wedbush analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HARP Harpoon Therapeutics
$21.40 /

+0.66 (+3.18%)

HARP Harpoon Therapeutics
$21.40 /

+0.66 (+3.18%)

05:00 Today Piper Sandler
Harpoon initial data for HPN424 'highly encouraging,' says Piper Sandler
05/29/20 Roth Capital
Harpoon Therapeutics price target raised to $31 from $25 at Roth Capital
05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
04/16/20 Citi
Citi opens 'positive 90-day catalyst watch' on Harpoon Therapeutics
HARP Harpoon Therapeutics
$21.40 /

+0.66 (+3.18%)

HARP Harpoon Therapeutics
$21.40 /

+0.66 (+3.18%)

HARP Harpoon Therapeutics
$21.40 /

+0.66 (+3.18%)

Conference/Events
ASGN management to meet virtually with SunTrust » 07:57
06/01/20
06/01
07:57
06/01/20
07:57
ASGN

ASGN

$61.77 /

-1.69 (-2.66%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASGN ASGN
$61.77 /

-1.69 (-2.66%)

ASGN ASGN
$61.77 /

-1.69 (-2.66%)

04/14/20 Wells Fargo
ASGN price target lowered to $57 from $80 at Wells Fargo
02/19/20
Fly Intel: Top five analyst downgrades
02/19/20 Jefferies
ASGN downgraded to Hold on 'new normal' of slower growth at Jefferies
02/19/20 Jefferies
ASGN downgraded to Hold from Buy at Jefferies
ASGN ASGN
$61.77 /

-1.69 (-2.66%)

Hot Stocks
Chuy's estimates positive EBITDA with average weekly sales above $54,000 » 07:55
06/01/20
06/01
07:55
06/01/20
07:55
CHUY

Chuy's

$16.00 /

-0.83 (-4.93%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

05/29/20 Jefferies
Bloomin' Brands upgraded to Buy on early read on reopenings at Jefferies
05/26/20 Stephens
Chuy's resumed with an Overweight at Stephens
04/23/20 BMO Capital
Chuy's upgraded to Market Perform from Underperform at BMO Capital
04/20/20 Raymond James
Chuy's price target raised to $17 from $14 at Raymond James
CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

Upgrade
Barclays upgrades 'underappreciated' Regal Beloit to Overweight » 07:55
06/01/20
06/01
07:55
06/01/20
07:55
RBC

Regal Beloit

$79.57 /

-1.48 (-1.83%)

Barclays analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBC Regal Beloit
$79.57 /

-1.48 (-1.83%)

RBC Regal Beloit
$79.57 /

-1.48 (-1.83%)

05:25 Today Barclays
Regal Beloit upgraded to Overweight from Equal Weight at Barclays
05/18/20 Oppenheimer
Regal Beloit upgraded to Outperform from Perform at Oppenheimer
05/14/20 KeyBanc
KeyBanc upgrades Regal Beloit to Overweight, suggests more short-cycle exposure
05/14/20 KeyBanc
Regal Beloit upgraded to Overweight from Sector Weight at KeyBanc
RBC Regal Beloit
$79.57 /

-1.48 (-1.83%)

Hot Stocks
Chuy's says 87 dining rooms in operation at varying levels of capacity » 07:54
06/01/20
06/01
07:54
06/01/20
07:54
CHUY

Chuy's

$16.00 /

-0.83 (-4.93%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

05/29/20 Jefferies
Bloomin' Brands upgraded to Buy on early read on reopenings at Jefferies
05/26/20 Stephens
Chuy's resumed with an Overweight at Stephens
04/23/20 BMO Capital
Chuy's upgraded to Market Perform from Underperform at BMO Capital
04/20/20 Raymond James
Chuy's price target raised to $17 from $14 at Raymond James
CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

Recommendations
LendingClub price target lowered to $8 from $25 at Wedbush » 07:54
06/01/20
06/01
07:54
06/01/20
07:54
LC

LendingClub

$5.35 /

-0.44 (-7.60%)

Wedbush analyst Henry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LC LendingClub
$5.35 /

-0.44 (-7.60%)

LC LendingClub
$5.35 /

-0.44 (-7.60%)

04/14/20 Maxim
LendingClub, Enova International, Elevate Credit cut to Hold at Maxim
04/14/20 Maxim
LendingClub downgraded to Hold from Buy at Maxim
02/19/20 Janney Montgomery Scott
Janney says LendingClub bank ownership benefits a second half of 2021 event
10/14/19 BTIG
LendingClub price target lowered to $23 from $30 at BTIG
LC LendingClub
$5.35 /

-0.44 (-7.60%)

LC LendingClub
$5.35 /

-0.44 (-7.60%)

Hot Stocks
Chuy's reports Q2 SSS down approx. 49.8% vs. last year » 07:53
06/01/20
06/01
07:53
06/01/20
07:53
CHUY

Chuy's

$16.00 /

-0.83 (-4.93%)

Chuy's Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

05/29/20 Jefferies
Bloomin' Brands upgraded to Buy on early read on reopenings at Jefferies
05/26/20 Stephens
Chuy's resumed with an Overweight at Stephens
04/23/20 BMO Capital
Chuy's upgraded to Market Perform from Underperform at BMO Capital
04/20/20 Raymond James
Chuy's price target raised to $17 from $14 at Raymond James
CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

CHUY Chuy's
$16.00 /

-0.83 (-4.93%)

Conference/Events
Ahold Delhaize management to meet virtually with Wolfe Research » 07:53
06/01/20
06/01
07:53
06/01/20
07:53
ADRNY

Ahold Delhaize

$0.00 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

05/28/20 Wolfe Research
Ahold Delhaize initiated with an Outperform at Wolfe Research
05/20/20 Morgan Stanley
Ahold Delhaize price target lowered to EUR 23.90 at Morgan Stanley
05/13/20 UBS
Ahold Delhaize downgraded to Sell from Neutral at UBS
04/28/20 Berenberg
Ahold Delhaize price target raised to EUR 20.20 from EUR 19.60 at Berenberg
ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

Downgrade
SVB Financial downgraded to Neutral from Buy at DA Davidson » 07:52
06/01/20
06/01
07:52
06/01/20
07:52
SIVB

SVB Financial

$214.72 /

-1.34 (-0.62%)

DA Davidson analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$214.72 /

-1.34 (-0.62%)

SIVB SVB Financial
$214.72 /

-1.34 (-0.62%)

06:46 Today DA Davidson
SVB Financial downgraded to Neutral from Buy at DA Davidson
04/27/20 SunTrust
SVB Financial price target raised to $210 from $165 at SunTrust
03/30/20 Wells Fargo
SVB Financial downgraded to Underweight from Equal Weight at Wells Fargo
03/30/20 Wells Fargo
SVB Financial downgraded to Underweight from Equal Weight at Wells Fargo
SIVB SVB Financial
$214.72 /

-1.34 (-0.62%)

Hot Stocks
Spero Therapeutics announces inducement grants under Nasdaq listing rule » 07:51
06/01/20
06/01
07:51
06/01/20
07:51
SPRO

Spero Therapeutics

$11.77 /

-0.09 (-0.76%)

Spero Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPRO Spero Therapeutics
$11.77 /

-0.09 (-0.76%)

SPRO Spero Therapeutics
$11.77 /

-0.09 (-0.76%)

05/11/20 H.C. Wainwright
Spero Therapeutics price target raised to $28 from $25 at H.C. Wainwright
11/05/19 H.C. Wainwright
Spero Therapeutics price target raised to $35 from $28 at H.C. Wainwright
10/03/19 Janney Montgomery Scott
Spero price target raised to $31 from $27 at Janney Montgomery Scott
10/02/19 Oppenheimer
Spero Therapeutics price target lowered to $20 from $30 at Oppenheimer
SPRO Spero Therapeutics
$11.77 /

-0.09 (-0.76%)

Recommendations
Allogene Therapeutics price target raised to $55 from $50 at Oppenheimer » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
ALLO

Allogene Therapeutics

$48.08 /

+1.48 (+3.18%)

Oppenheimer analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

07:46 Today Raymond James
Allogene Therapeutics downgraded to Market Perform from Outperform at Raymond James
07:08 Today Goldman Sachs
Allogene Therapeutics price target raised to $66 from $45 at Goldman Sachs
06:48 Today JMP Securities
Allogene Therapeutics price target raised to $53 from $37 at JMP Securities
06:15 Today Raymond James
Allogene Therapeutics downgraded to Market Perform at Raymond James
ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

Periodicals
YouTube seeks TV advertising dollars despite obstacles, WSJ reports » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
GOOG

Alphabet

$1,430.80 /

+14.43 (+1.02%)

, GOOGL

Alphabet Class A

$1,435.82 /

+17.61 (+1.24%)

YouTube is looking for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

Hot Stocks
Acreage Holdings enters two funding agreements for up to $60M gross proceeds » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
ACRGF

Acreage Holdings

$0.00 /

+ (+0.00%)

Acreage Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRGF Acreage Holdings
$0.00 /

+ (+0.00%)

ACRGF Acreage Holdings
$0.00 /

+ (+0.00%)

02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
Acreage Holdings initiated with a Neutral at Cantor Fitzgerald
10/31/19 Ladenburg
Cannabis sector investor sentiment is now 'very low,' says Ladenburg
09/20/19 MKM Partners
MKM starts Acreage at Buy on 'extreme disconnect' from Canopy offer
ACRGF Acreage Holdings
$0.00 /

+ (+0.00%)

Conference/Events
Arcosa management to meet virtually with Oppenheimer » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
ACA

Arcosa

$38.16 /

-0.12 (-0.31%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACA Arcosa
$38.16 /

-0.12 (-0.31%)

ACA Arcosa
$38.16 /

-0.12 (-0.31%)

03/20/20 DA Davidson
Arcosa price target lowered to $40 from $52 at DA Davidson
09/18/19 Sidoti
Arcosa initiated with a Buy at Sidoti
ACA Arcosa
$38.16 /

-0.12 (-0.31%)

ACA Arcosa
$38.16 /

-0.12 (-0.31%)

Initiation
Kala Pharmaceuticals assumed with an Outperform at Oppenheimer » 07:49
06/01/20
06/01
07:49
06/01/20
07:49
KALA

Kala Pharmaceuticals

$12.28 /

+0.04 (+0.33%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

05/27/20 JPMorgan
Kala Pharmaceuticals assumed with an Overweight at JPMorgan
05/27/20 H.C. Wainwright
Kala Pharmaceuticals price target raised to $17 from $14 at H.C. Wainwright
05/13/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data
03/20/20 Wedbush
Kala Pharmaceuticals added to Best Ideas List at Wedbush
KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

Hot Stocks
Mayo Clinic joins Biomerica's InFoods IBS diagnostic-guided therapy trial » 07:48
06/01/20
06/01
07:48
06/01/20
07:48
BMRA

Biomerica Inc

$6.43 /

-0.08 (-1.23%)

Biomerica announced they…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRA Biomerica Inc
$6.43 /

-0.08 (-1.23%)

BMRA Biomerica Inc
$6.43 /

-0.08 (-1.23%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.